117 related articles for article (PubMed ID: 17210228)
1. Novel therapeutic targets in lung cancer: Inhibitor of apoptosis proteins from laboratory to clinic.
Dean EJ; Ranson M; Blackhall F; Holt SV; Dive C
Cancer Treat Rev; 2007 Apr; 33(2):203-12. PubMed ID: 17210228
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIF-dependent apoptotic cell death in non-small cell lung carcinoma cells.
Hajji N; Wallenborg K; Vlachos P; Nyman U; Hermanson O; Joseph B
Oncogene; 2008 May; 27(22):3134-44. PubMed ID: 18071312
[TBL] [Abstract][Full Text] [Related]
3. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation.
Checinska A; Hoogeland BS; Rodriguez JA; Giaccone G; Kruyt FA
Exp Cell Res; 2007 Apr; 313(6):1215-24. PubMed ID: 17291493
[TBL] [Abstract][Full Text] [Related]
4. Targeting apoptosis in prostate cancer: focus on caspases and inhibitors of apoptosis proteins.
Watson RW; Fitzpatrick JM
BJU Int; 2005 Dec; 96 Suppl 2():30-4. PubMed ID: 16359436
[TBL] [Abstract][Full Text] [Related]
5. New targets for non-small-cell lung cancer therapy.
Alvarez M; Roman E; Santos ES; Raez LE
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567
[TBL] [Abstract][Full Text] [Related]
6. Correspondence re: L. Yang et al., Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. Cancer Res., 63: 831-837, 2003.
Kruyt FA; Checinska A; Giaccone G; Ferreira CG
Cancer Res; 2003 Oct; 63(19):6566-7; author reply 6568. PubMed ID: 14559854
[No Abstract] [Full Text] [Related]
7. The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer.
Nachmias B; Ashhab Y; Ben-Yehuda D
Semin Cancer Biol; 2004 Aug; 14(4):231-43. PubMed ID: 15219616
[TBL] [Abstract][Full Text] [Related]
8. IAP proteins: sticking it to Smac.
Duckett CS
Biochem J; 2005 Jan; 385(Pt 1):e1-2. PubMed ID: 15588250
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice.
Schimmer AD
Cancer Res; 2004 Oct; 64(20):7183-90. PubMed ID: 15492230
[TBL] [Abstract][Full Text] [Related]
10. Novel 2-step synthetic indole compound 1,1,3-tri(3-indolyl)cyclohexane inhibits cancer cell growth in lung cancer cells and xenograft models.
Lee CH; Yao CF; Huang SM; Ko S; Tan YH; Lee-Chen GJ; Wang YC
Cancer; 2008 Aug; 113(4):815-25. PubMed ID: 18618576
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets.
Motadi LR; Misso NL; Dlamini Z; Bhoola KD
Int Immunopharmacol; 2007 Dec; 7(14):1934-47. PubMed ID: 18039530
[TBL] [Abstract][Full Text] [Related]
12. The inhibitors of apoptosis: there is more to life than Bcl2.
Liston P; Fong WG; Korneluk RG
Oncogene; 2003 Nov; 22(53):8568-80. PubMed ID: 14634619
[TBL] [Abstract][Full Text] [Related]
13. Caspase regulation in non-small cell lung cancer and its potential for therapeutic exploitation.
Fennell DA
Clin Cancer Res; 2005 Mar; 11(6):2097-105. PubMed ID: 15788654
[TBL] [Abstract][Full Text] [Related]
14. Caspase-2 is resistant to inhibition by inhibitor of apoptosis proteins (IAPs) and can activate caspase-7.
Ho PK; Jabbour AM; Ekert PG; Hawkins CJ
FEBS J; 2005 Mar; 272(6):1401-14. PubMed ID: 15752357
[TBL] [Abstract][Full Text] [Related]
15. The IAP proteins: caspase inhibitors and beyond.
Richter BW; Duckett CS
Sci STKE; 2000 Aug; 2000(44):pe1. PubMed ID: 11752601
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of a novel bis-aziridinylnaphthoquinone (AZ4) mediating cell cycle arrest and apoptosis in non-small cell lung cancer cell line NCI-H460.
Shyu KG; Huang ST; Kuo HS; Cheng WP; Lin YL
Acta Pharmacol Sin; 2007 Apr; 28(4):559-66. PubMed ID: 17376296
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor of apoptosis proteins as targets for anticancer therapy.
Fulda S
Expert Rev Anticancer Ther; 2007 Sep; 7(9):1255-64. PubMed ID: 17892425
[TBL] [Abstract][Full Text] [Related]
18. pp32/PHAPI determines the apoptosis response of non-small-cell lung cancer.
Hoffarth S; Zitzer A; Wiewrodt R; Hähnel PS; Beyer V; Kreft A; Biesterfeld S; Schuler M
Cell Death Differ; 2008 Jan; 15(1):161-70. PubMed ID: 17962813
[TBL] [Abstract][Full Text] [Related]
19. Isokotomolide A, a new butanolide extracted from the leaves of Cinnamomum kotoense, arrests cell cycle progression and induces apoptosis through the induction of p53/p21 and the initiation of mitochondrial system in human non-small cell lung cancer A549 cells.
Chen CY; Hsu YL; Chen YY; Hung JY; Huang MS; Kuo PL
Eur J Pharmacol; 2007 Nov; 574(2-3):94-102. PubMed ID: 17707793
[TBL] [Abstract][Full Text] [Related]
20. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
